HPTLC Method Development and Validation of Cefpodoxime Proxetil and Ofloxacin in Bulk and Combined Tablet Dosage form

Order of Publishing in Issue: 
1
Volume :10
Issue :1
January, 2016
Page No: 
56-63
Authors: 
Deepshikha Patle
Address: 
Faculty of Pharmaceutical Sciences, PCTE Group of Institutes, Ludhiana, Punjab, India-141004

The aim of the study is to develop and validate a simple, precise and rapid high performance thin layer chromatographic (HPTLC) method for Cefpodoxime Proxetil and Ofloxacin in bulk and combined tablet dosage form. Chromatographic separation was accomplished by using precoated silica gel 60F254 TLC plate (20cm x10cm) with 250μm thickness with mobile phase Chloroform in ratio methanol (9:1 v/v). Detection was performed at isobestic point 255 nm for both drugs. The retesion factor of Cefpodoxime Proxetil and Ofloxacin were found to be 0.63 and 0.25, respectively. The reliability of the method was assessed by evaluation of linearity range (500-3000 ng/spot for both Cefpodoxime proxetil and ofloxacin respectively. Accuracy (99.56 % for Cefpodoxime Proxetil and 99.33% for Ofloxacin), and specificity, in compliance with ICH guidelines.

Keywords: 
Cefpodoxime proxetil, Ofloxacin, High performance thin layer chromatography (HPTLC), method development, validation.
AttachmentSize
PDF813.64 KB

 
To download full text articles and issues in PDF at no cost.All you have to do is fill out a brief registration form. It's easy and it's free. At any time, you may request removal of your contact information from our database.
Click here to Register | Click here if you have already registered

2018 ABAP Awards

Invitation for Nominations to 2019 ABAP Awards
The Association of Biotechnology and Pharmacy invites nominations for the following awards from the eligible talented people with proven track record and achievements on or before August 31, 2019 in the prescribed format.

DOWNLOAD CIRCULAR | APPLICATION FORM

AWARDS

Upcoming 0 events

  • No upcoming events available

User login